Citations 143

GENE-29. DLL3 AND ETV1 ARE INACTIVATED/METHYLATED IN CIC WILD-TYPE, IDH-MUTATED, 1p/19q-CODELETED GLIOMA

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi109-vi109

10.1093/neuonc/noy148.455

Insurance correlates with improved access to care and outcome among glioblastoma patients

Neuro-Oncology | June 11, 2018 | Volume: 20 | Issue: 10 | Pages: 1374-1382

10.1093/neuonc/noy102 | PMID 29893906

Open Microvascular Decompression

Advances in Medical Diagnosis, Treatment, and Care | March 27, 2018 | Volume: No volume available | Issue: No issue available | Pages: 70-103

10.4018/978-1-5225-5349-6.ch004

Microvascular decompression (MVD) is a neurosurgical procedure used to treat various neuralgias of the cranial nerves. The clinical presentation, natural history, pathophysiology, and medical management of trigeminal neuralgia, hemifacial spasm, glossopharyngeal neuralgia, and nervus intermedius neuralgia is reviewed. A thorough discussion on the retrosigmoid approach for decompression of cranial nerves is presented, along with newer techniques and controversies on adjuvant therapies and neuromonitoring. The surgical outcomes of MVD are discussed, along with alternative techniques to open MVD.